Early Treatment with Addition of Low Dose Prednisolone to Methotrexate Improves Therapeutic Outcome in Severe Psoriatic Arthritis

Psoriatic arthritis (PsA) is increasingly being recognized to cause progressive joint damage and disability. PsA unresponsive to non-steroidal anti-inflammatory drugs (NSAIDs), the conventional first-line choice of treatment, is usually managed with disease-modifying antirheumatic drugs (DMARDs) esp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mahajan, Vikram K, Sharma, Anju Lath, Chauhan, Pushpinder S, Mehta, Karaninder S, Sharma, Nand Lal
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2013
Matèries:
E-Therapeutic Round
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667301/
https://ncbi.nlm.nih.gov/pubmed/23723489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.110847
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars